On the basis that propranolol antagonizes β1- and β2-AR, but not β3-AR [9], these data suggest that β1- and/or β2-AR signaling may have some pro-obesity activity in the context of high fat diet-induced SNS activation. Here, ADRB3 is linked to obesity disorder.